| Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues K Madaan, S Kumar, N Poonia, V Lather, D Pandita Journal of pharmacy & bioallied sciences 6 (3), 139, 2014 | 390 | 2014 |
| Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol D Pandita, S Kumar, N Poonia, V Lather Food Research International 62, 1165-1174, 2014 | 175 | 2014 |
| Cosmeceuticals: An emerging concept VL Harish Dureja, Deepak Kaushik, Meenal Gupta, Vipin Kumar Indian Journal of Pharmacology 37, 155-160, 2005 | 149* | 2005 |
| Updates on aldose reductase inhibitors for management of diabetic complications and non-diabetic diseases A Singh Grewal, S Bhardwaj, D Pandita, V Lather, B Singh Sekhon Mini Reviews in Medicinal Chemistry 16 (2), 120-162, 2016 | 120 | 2016 |
| Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel D Pandita, A Ahuja, V Lather, B Benjamin, T Dutta, T Velpandian, RK Khar Aaps Pharmscitech 12 (2), 712-722, 2011 | 90 | 2011 |
| Hybrid poly (lactic-co-glycolic acid) nanoparticles: design and delivery prospectives D Pandita, S Kumar, V Lather Drug discovery today 20 (1), 95-104, 2015 | 86 | 2015 |
| Nanostructured lipid carriers: versatile oral delivery vehicle N Poonia, R Kharb, V Lather, D Pandita Future science OA 2 (3), FSO135, 2016 | 73 | 2016 |
| Dissolution behavior of β-cyclodextrin molecular inclusion complexes of aceclofenac K Dua, K Pabreja, MV Ramana, V Lather Journal of pharmacy and bioallied sciences 3 (3), 417, 2011 | 63 | 2011 |
| Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique D Pandita, A Ahuja, T Velpandian, V Lather, T Dutta, RK Khar Die Pharmazie-An International Journal of Pharmaceutical Sciences 64 (5 …, 2009 | 63 | 2009 |
| Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus A Singh Grewal, B Singh Sekhon, V Lather Mini Reviews in Medicinal Chemistry 14 (7), 585-602, 2014 | 55 | 2014 |
| Topological models for the prediction of anti-HIV activity of dihydro (alkylthio)(naphthylmethyl) oxopyrimidines V Lather, AK Madan Bioorganic & medicinal chemistry 13 (5), 1599-1604, 2005 | 54 | 2005 |
| Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid K Madaan, V Lather, D Pandita Drug delivery 23 (1), 254-262, 2016 | 42 | 2016 |
| QSAR models for prediction of glycogen synthase kinase‐3β inhibitory activity of indirubin derivatives V Lather, R Kristam, JS Saini, R Kristam, NA Karthikeyan, VN Balaji QSAR & Combinatorial Science 27 (6), 718-728, 2008 | 34 | 2008 |
| Stability indicating simplified HPLC method for simultaneous analysis of resveratrol and quercetin in nanoparticles and human plasma S Kumar, V Lather, D Pandita Food chemistry 197, 959-964, 2016 | 31 | 2016 |
| Design, synthesis and biological evaluation of novel thiazol-2-yl benzamide derivatives as glucokinase activators N Charaya, D Pandita, AS Grewal, V Lather Computational biology and chemistry 73, 221-229, 2018 | 29 | 2018 |
| Mesoporous silica nanoparticles: a smart nanosystem for management of breast cancer N Poonia, V Lather, D Pandita Drug Discovery Today 23 (2), 315-332, 2018 | 29 | 2018 |
| Green synthesis of therapeutic nanoparticles: an expanding horizon S Kumar, V Lather, D Pandita Nanomedicine 10 (15), 2451-2471, 2015 | 29 | 2015 |
| Application of graph theory: Topological models for prediction of CDK-1 inhibitory activity of aloisines V Lather, AK Madan Croatica chemica acta 78 (1), 55-61, 2005 | 29 | 2005 |
| Topological models for the prediction of HIV-protease inhibitory activity of tetrahydropyrimidin-2-ones V Lather, AK Madan Journal of Molecular Graphics and Modelling 23 (4), 339-345, 2005 | 28 | 2005 |
| Toward the design of mutation‐resistant enzyme inhibitors: further evaluation of the substrate envelope hypothesis V Kairys, MK Gilson, V Lather, CA Schiffer, MX Fernandes Chemical biology & drug design 74 (3), 234-245, 2009 | 27 | 2009 |
